UiPath Option Alert: Aug 15 $16 Puts at the Bid: 1600 vs 3 OI; Earnings 3/12 After Close 

UiPath Option Alert: Aug 15 $16 Puts at the Bid: 1600 @ $3.15 vs 3 OI; Earnings 3/12 After Close Ref=$14.095

UiPath (NYSE:PATH) 주식

UiPath

UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

Equities

News

Markets

ETFs

ILMN

PATH

PLTR

ROKU

TWST

캐시 우드가 이끄는 아크 인베스트가 월요일(10일)에 상당한 규모의 거래를 했다. 가장 눈에 띄는 것은 팔란티어 테크놀로지스(NASDAQ:PLTR) 주식의 매각이었는데, 팔란티어 주가가 인상적인 재무 실적 이후 계속 상승세를 이어가고 있었기 때문이다.

아크 인베스트, 팔란티어 주식 1,600만 달러 상당 추가 매각

Short Sellers

Tech

ACCD

AMZN

ARKF

ARKG

ARKK

ARKQ

ARKW

ARKX

HOOD

RBLX

RKLB

금요일에 캐시 우드의 아크 인베스트가 아마존닷컴(NASDAQ:AMZN), 로빈후드 마켓(NASDAQ:HOOD), 팔란티어 테크놀로지스(NYSE:PLTR) 그리고 로블록스(NYSE:RBLX) 등 여러 주요 기업의 주식에 대해 중요한 거래를 진행했다.

아크 인베스트는 팔란티어 지분을 줄이고 아마존, 로블록스 및 일루미나에 대한 큰 베팅

ABSI

ESLT

NTLA

OKLO

화요일(21일) 캐시 우드가 이끄는 아크 인베스트는 애콜레이드(NASDAQ:ACCD), 디어(NYSE:DE), 인텔리아 테라퓨틱스(NASDAQ:NTLA), 유아이패스(NYSE:PATH), 카메코(NYSE:CCJ), 오클로(NYSE:OKLO), 일루미나(NASDAQ:ILMN), 엘빗 시스템즈(NASDAQ:ESLT), 앱사이(NASDAQ:ABSI)와 관련된 상당한 거래를 진행했다. 

아크 인베스트, 트럼프의 정책에 따라 방산주·에너지주 투자

UiPath Inc

Pathfinder Bancorp Inc

PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy Inc

Pathfinder Ventures Inc

PATHFINDER VENTURES INC by PATHFINDER VENTURES INC.

Pathward Financial Inc

Contracts

UiPath Enters Into New Global Consulting Agreement With Major EMR Platform, Expanding Services In 16 Countries

WIIM

ADBE

AMOD

APPS

ASAN

BILL

BLIN

BTDR

CDNS

CFLT

CIFR

CLSK

Core Scientific, Inc. - Class A Common Stock

CORZ

CVLT

CYBR

DDOG

ESTC

FTNT

GTLB

HUBS

INTU

IREN

KVYO

MARA

MSTR

NTNX

ORCL

PANW

RBRK

RIOT

SAIL

SNPS

SOUN

TEAM

ZETA

Shares of software companies are trading lower amid overall market weakness on US consumer and economic concerns.

UiPath's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) short percent of float has risen 10.66% since its last report. The company recently reported that it has 32.51 million shares sold short, which is 7.68% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.77 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>UiPath Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739301317_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UiPath has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing UiPath's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, UiPath's peer group average for short interest as a percentage of float is 5.00%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Ideas

Trading Ideas

Looking Into UiPath's Recent Short Interest

Ark Invest, led by Cathie Wood, made significant trades on Monday. Among the most prominent was the sale of shares in Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), as the stock continued its upward trajectory following impressive financial results.
The Palantir Trade
On Monday, Ark Invest executed a notable trade involving Palantir selling 135,775 shares through its ARKK ETF. This move comes after <a href="https://www.benzinga.com/25/02/43550434/cathie-wood-dumps-10-million-palantir-shares-at-peak-sells-robinhood-and-reddit-ark-invest-loads-up-on-qualcomm-stock">Palantir&#8217;s stock reached new all-time highs</a> following its impressive <a href="https://in.benzinga.com/news/earnings/earnings-beats/25/02/43468342/palantir-rockets-on-strong-q4-2024-was-only-a-dress-rehearsal-for-ai-growth-says-analyst">fourth-quarter earnings report</a>. The company reported revenue of $827.52 million, surpassing analyst expectations of $775.91 million, and adjusted earnings of 14 cents per share, beating the forecast of 11 cents per share.
The stock closed at $116.65 on Monday, marking a 5.23% increase. The 52-week high for the stock is $116.76. In the after-hours trading, it was seen at $117.56. The sale of these shares amounted to approximately $15.83 million, based on Monday&#8217;s closing price. Despite the impressive financial results, Ark Invest has been <a href="https://www.benzinga.com/25/02/43550434/cathie-wood-dumps-10-million-palantir-shares-at-peak-sells-robinhood-and-reddit-ark-invest-loads-up-on-qualcomm-stock">strategically reducing</a> its position in Palantir.
Other Key Trades:
<ul>
<li>UiPath Inc. (PATH) &#8211; Sold 459,205 shares through ARKK and 33,061 shares through ARKW.</li>
<li>Roku Inc.(ROKU) &#8211; Sold 78,654 shares through ARKK.</li>
<li>Twist Bioscience Corp. (TWST) &#8211; Bought 268,210 shares through ARKK.</li>
<li>Illumina Inc. (ILMN) &#8211; Bought 85,621 shares through ARKK and 14,846 shares through ARKG.</li>
</ul>
Image via Shutterstock
Read Next: 
<ul>
<li><a href="https://in.benzinga.com/markets/equities/25/02/43613133/trumps-25-tarrifs-a-self-inflicted-wound-says-economist-amid-warnings-of-fewer-american-jobs-peter-schiff-says-youll-pay-more-for-cars-and-homes">Trump&#8217;s 25% Tarrifs A &#8216;Self-Inflicted Wound,&#8217; Says Economist Amid Warnings Of Fewer American Jobs — Peter Schiff Says You&#8217;ll Pay More For Cars And Homes</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs

On Friday, Cathie Wood's Ark Invest made significant trades involving a number of prominent companies such as&nbsp;Amazon.com Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>),&nbsp;Robinhood Markets Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>),&nbsp;Palantir Technologies Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>), and&nbsp;Roblox Corp&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), among others.
The AMZN Trade
Ark Invest, across its ARK Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>), ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>), ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>), ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>), and ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) funds, purchased shares of&nbsp;Amazon.com Inc. The total number of shares bought across all ETFs was 72,457.
Given Amazon&#8217;s closing price of $229.15 on the day of the trade, the total value of purchases stands at $16.6 million.
The Roblox Trade
Ark Invest bought a cumulative 48,541 shares of Roblox across its ARKF, ARKK, and ARKW funds. The value of the trade stands at $3.21 million, based on Friday's closing price of Roblox stock of $66.28.
The Illumina Trade
Ark Invest bought a cumulative 107,459 shares of Illumina across its ARK Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and ARKK funds. The value of the trade stands at $11.93 million, based on Friday's closing price of Illumina stock of $111.06.
The PLTR Trade
Ark Invest sold 8,150 shares of Palantir from its ARKF fund. The value of the trade stands at $903,428, based on Friday's closing price of Palantir stock of $110.85. The Alex Karp-led company reached an all-time high of $116 on Thursday. 
Other Key Trades
<ul>
<li>Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>): 401,962 shares sold through ARKG fund.</li>
<li>Twist Bioscience Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>): 44,562 shares bought through <a>ARKG and ARKK funds.</a></li>
<li>10X Genomics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>): 185,249 shares bought through ARKG and ARKK funds.</li>
<li>PagerDuty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>): 85,420 shares bought through ARKK and ARKW funds.</li>
<li>Cloudflare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>): 18,319 shares sold through ARKW fund.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>): 996,441 shares sold through ARKK and ARKW funds.</li>
<li>Robindhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>): 113,777 shares sold through ARKF, ARKK, and ARKW funds.</li>
<li>Rocket Lab USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>): 70,252 shares sold through ARKQ and ARKX funds.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43577591/legendary-short-seller-jim-chanos-warns-of-market-speculation-reaching-historic-extremes-wall-street-has-a-printi">Legendary Short Seller Jim Chanos Warns Of Market Speculation Reaching Historic Extremes: ‘Wall Street Has A Printing Press Too'</a></li>
</ul>
Photo courtesy: Ark Invest

Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday

APPN

CRWD

DOCU

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

MNDY

PEGA

Shares of software companies are trading lower after the Fed kept rates unchanged and noted that inflation remains somewhat elevated.

On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), Deere &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), Intellia Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Cameco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>), Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>), and Absci Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>).
The trades include defense and energy companies, which have been in focus since the inauguration of Donald Trump. The President signed orders on Monday aimed at making it cheaper for companies to produce oil and gas, which could have an impact on energy companies. Defense stocks have also been in focus due to expectations of a pro-Israel stance from the new administration.
The NTLA Trade
The Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) collectively purchased 91,889 shares of Intellia Therapeutics Inc. Based on the closing price of $9.94, the total value of the trade amounts to approximately $913,580.06. This move indicates Ark&#8217;s continued confidence in the gene-editing sector.
The PATH Trade
Ark Invest sold 21,879 shares of UiPath Inc. through its ARKK fund. Given the closing price of $13.33, the trade is valued at around $291,712.07. This sale suggests a shift in Ark&#8217;s stance on the automation software company.
The DE Trade
Ark Invest&#8217;s ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>) and ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) purchased a total of 3,474 shares of Deere &amp; Co. With the closing price at $463.15, the trade is worth approximately $1,607,571.10.
The CCJ Trade
Ark Invest also bought 17,504 shares of Cameco Corp (CCJ) through its ARKQ fund, valued at approximately $937,589.44 at the closing price of $53.56.
Other Key Trades:
<ul>
<li>Oklo Inc: Ark Invest sold 50333 shares through ARKQ.</li>
<li>Elbit Systems: Ark Invest Sold 2074 shares through ARKQ and 627 shares through ARKX.</li>
<li>Illumina Inc: Ark Invest bought 15876 shares through ARKG.</li>
<li>Absci Corp: Ark Invest bought 79411 shares through ARKG.</li>
<li>Accolade Inc: Ark Invest sold 466,337 shares through ARKG.</li>
</ul>
Photo courtesy: Ark Invest

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies

On Friday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>), Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), and Ibotta Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>).
The Tempus AI Trade
Ark Invest&#8217;s Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) funds made substantial purchases of Tempus AI shares. The ARKG fund acquired 27,188 shares, while the ARKK fund bought a whopping 159,344 shares.
Based on the closing price of $35.15, the total value of these trades is approximately $6.57 million. This move aligns with Ark Invest&#8217;s <a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">recent trend of investing</a> in AI-driven companies.
The CRSP Trade
Ark Invest&#8217;s ARKG and ARKK funds also bought shares of CRISPR Therapeutics. The ARKG fund purchased 21,730 shares, while the ARKK fund added 125,690 shares.
Given the closing price of $40.53, the total value of these trades is approximately $5.96 million.
The PATH, RBLX, and RDDT Trades
On the other hand, Ark Invest sold shares of UiPath, Roblox, and Reddit. The ARKK fund offloaded 199,224 shares of UiPath, and 148,591 shares of Roblox, and the ARKW fund sold 5,215 shares of Reddit.
These sales indicate a shift in Ark Invest&#8217;s portfolio strategy.
Other Key Trades:
<ul>
<li>Ibotta Inc.: Ark Invest&#8217;s Ark Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) fund bought 4,364 shares of Ibotta.</li>
<li>Accolade Inc.: The ARKG fund sold 284,775 shares of Accolade.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In First 2 Weeks Of 2025</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Benzinga YouTube and Unsplash

CRSP

IBTA

RDDT

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$135.00</td>
<td>$35.8K</td>
<td>84.7K</td>
<td>106.9K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$237.50</td>
<td>$42.3K</td>
<td>10.2K</td>
<td>26.6K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$425.00</td>
<td>$39.1K</td>
<td>10.1K</td>
<td>12.7K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$400.00</td>
<td>$64.6K</td>
<td>12.7K</td>
<td>11.3K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$32.00</td>
<td>$215.4K</td>
<td>286</td>
<td>2.1K</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$640.00</td>
<td>$1.2 million</td>
<td>749</td>
<td>310</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$240.00</td>
<td>$90.0K</td>
<td>2.0K</td>
<td>276</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$690.00</td>
<td>$394.9K</td>
<td>1</td>
<td>266</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$20.00</td>
<td>$26.5K</td>
<td>1.2K</td>
<td>116</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$180.00</td>
<td>$83.0K</td>
<td>2.0K</td>
<td>112</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option trade that happens to be bullish, expiring in 2 day(s) on January 17, 2025. This event was a transfer of 199 contract(s) at a $135.00 strike. The total cost received by the writing party (or parties) was $35.8K, with a price of $180.0 per contract. There were 84798 open contracts at this strike prior to today, and today 106920 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 225 contract(s) at a $237.50 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $42.3K, with a price of $188.0 per contract. There were 10238 open contracts at this strike prior to today, and today 26613 contract(s) were bought and sold. 
• Regarding MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we observe a call option sweep with bearish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 126 contract(s) at a $425.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $39.1K, with a price of $315.0 per contract. There were 10125 open contracts at this strike prior to today, and today 12793 contract(s) were bought and sold. 
• Regarding MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 380 contract(s) at a $400.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $64.6K, with a price of $170.0 per contract. There were 12705 open contracts at this strike prior to today, and today 11323 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a call option sweep that happens to be bearish, expiring in 212 day(s) on August 15, 2025. This event was a transfer of 258 contract(s) at a $32.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $215.4K, with a price of $835.0 per contract. There were 286 open contracts at this strike prior to today, and today 2177 contract(s) were bought and sold. 
• For INTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), we notice a call option trade that happens to be bearish, expiring in 156 day(s) on June 20, 2025. This event was a transfer of 300 contract(s) at a $640.00 strike. The total cost received by the writing party (or parties) was $1.2 million, with a price of $4320.0 per contract. There were 749 open contracts at this strike prior to today, and today 310 contract(s) were bought and sold. 
• For MDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>), we notice a put option trade that happens to be bearish, expiring in 16 day(s) on January 31, 2025. This event was a transfer of 150 contract(s) at a $240.00 strike. The total cost received by the writing party (or parties) was $90.0K, with a price of $600.0 per contract. There were 2089 open contracts at this strike prior to today, and today 276 contract(s) were bought and sold. 
• Regarding ASML (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>), we observe a call option sweep with neutral sentiment. It expires in 121 day(s) on May 16, 2025. Parties traded 43 contract(s) at a $690.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $394.9K, with a price of $9183.0 per contract. There were 1 open contracts at this strike prior to today, and today 266 contract(s) were bought and sold. 
• For PATH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), we notice a call option sweep that happens to be bullish, expiring in 730 day(s) on January 15, 2027. This event was a transfer of 100 contract(s) at a $20.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $265.0 per contract. There were 1280 open contracts at this strike prior to today, and today 116 contract(s) were bought and sold. 
• For SNOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), we notice a call option trade that happens to be bearish, expiring in 156 day(s) on June 20, 2025. This event was a transfer of 50 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $83.0K, with a price of $1660.0 per contract. There were 2017 open contracts at this strike prior to today, and today 112 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AAPL

ASML

MSFT

NVDA

SMCI

SNOW

10 Information Technology Stocks Whale Activity In Today's Session

Needham analyst Scott Berg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Hold to Hold.

Reiteration

Analyst Ratings

Needham Reiterates Hold on UiPathto Hold

In the latest quarter, 9 analysts provided ratings for UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for UiPath, revealing an average target of $15.67, a high estimate of $18.00, and a low estimate of $13.00. This current average represents a 2.06% decrease from the previous average price target of $16.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736532017_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of UiPath by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeff Hickey</td>
<td>UBS</td>
<td>Announces</td>
<td>Sell</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to UiPath. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of UiPath compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of UiPath's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of UiPath's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PATH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on UiPath analyst ratings.</a>
<h2>Get to Know UiPath Better</h2>
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
<h3>UiPath's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, UiPath showcased positive performance, achieving a revenue growth rate of 8.82% as of 31 October, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: UiPath's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -3.0%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): UiPath's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.6% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.4%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into UiPath Stock: Analyst Perspectives (9 Ratings)

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and lowers the price target from $16 to $15.

Price Target

Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $15

ANET

APLD

ARBB

CMBM

CPSH

CRNT

DELL

HIMX

IONQ

LDTC

LIDR

LOGI

MOBBW

OKTA

ORKT

PERF

SHOP

SMSI

VRME

VSAT

VUZI

XTIA

ZENV

Shares of companies within the broader tech sector are trading higher amid market strength and may be in reaction to Microsoft's plan to invest approximately $80 billion into AI data center development in FY25.

U.S. stocks were higher, with the Dow Jones index gaining over 200 points on Monday.
Shares of fuboTV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) rose sharply during Monday's session after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a <a href="https://www.benzinga.com/25/01/42816545/fubotv-and-disney-near-merger-to-create-second-largest-digital-tv-provider-shares-soar-report">virtual MVPD company.</a>
fuboTV shares jumped 140% to $3.4501 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) surged 21.7% to $23.18 after the company announced it raised $86 million in funding for December and $167 million for 2024.</li>
<li>Paycor HCM, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) gained 21.5% to $22.52. Needham analyst Scott Berg reiterated Paycor HCM with a Buy and maintained a $20 price target.</li>
<li>Vuzix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) surged 21.4% to $5.33.</li>
<li>Amprius Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) rose 19% to $3.9000.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) gained 18.3% to $18.08 after the company revealed plans for 2025 including layoffs of approximately 400 employees and other spending reduction measures.</li>
<li>Ceragon Networks Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNT#NASDAQ">CRNT</a>) rose 16.8% to $5.53.</li>
<li>LanzaTech Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) gained 16% to $1.9500.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) surged 14% to $19.96.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) rose 11% to $36.97.</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) gained 10.5% to $99.29.</li>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares rose 10.5% to $2.9100.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) gained 9% to $4.0124.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares gained 8.8% to $20.71.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) rose 8% to $291.92.</li>
<li>Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) rose 7.9% to $21.88 after BMO Capital upgraded the stock from Market Perform to Outperform and raised its price target from $25 to $31.</li>
<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) rose 7.8% to $22.24 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $19 to $27.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) gained 6.9% to $14.19.</li>
<li>Teradyne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TER#NYSE">TER</a>) surged 6.2% to $138.79 after Northland Capital Markets upgraded the stock from Market Perform to Outperform and raised its price target from $117 to $154.</li>
</ul>
Now Read This: 
<ul>
<li><a href="Cramer: 'At This Point,' SoundHound AI Rally 'Is A Short Squeeze'">Cramer: &#8216;At This Point,&#8217; SoundHound AI Rally &#8216;Is A Short Squeeze&#8217;</a></li>
</ul>

AMPX

COIN

CPRI

FUBO

LNZA

PLUG

PYCR

QUBT

RGTI

SEDG

SERV

FuboTV, Serve Robotics, SolarEdge Technologies And Other Big Stocks Moving Higher On Monday

ADSK

AGYS

BTCS

BTOG

CWAN

DSGX

ETWO

EVCM

EXFY

FICO

FRSH

GREE

GRYP

HTCR

LMFA

LSPD

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

NCTY

NICE

PCOR

PRCH

RAMP

SDIG

TRAK

TZUP

UPLD

Shares of stocks in the broader software sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

UBS analyst Jeff Hickey initiates coverage on UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sell rating and announces Price Target of $14.

Initiation

UBS Initiates Coverage On UiPath with Sell Rating, Announces Price Target of $14

U.S. competitiveness takes center stage in 2025 with four key investment themes—energy independence, defense innovation, infrastructure, and automation—poised to bolster portfolio growth. Global X's 2025 Investment Outlook, led by Scott Helfstein, highlights these transformative trends as critical drivers of resilience <a href="https://www.benzinga.com/topic/us-economy">in the coming year.</a>
<h2 class="wp-block-heading">Infrastructure Gets A Glow-Up</h2>
America&#8217;s infrastructure renaissance is going full throttle, with $700 billion in spending set to energize construction, equipment, and materials companies. This may bode well for investors in the Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>).
These stalwarts of the old economy are reinventing themselves with cutting-edge tech to expand margins—all while trading at attractive valuations compared to the broader S&amp;P 500.
<h2 class="wp-block-heading">The Defense Play: Beyond Jets &amp; Ships</h2>
Global tensions are driving a pivot from traditional defense platforms to high-tech solutions like AI-driven drones and cybersecurity systems. 
Palantir Technologies Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) Artificial Intelligence Platform and International Business Machines Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) WatsonX AI come to mind here.
Defense revenues are expected to jump nearly 10%, with margins climbing from 5.2% to 7.6%. Success will favor those adopting automation and next-generation technologies in this competitive landscape.
Read Also: <a href="https://www.benzinga.com/news/small-cap/24/12/42438879/manufacturing-tariffs-small-cap-could-steal-the-show-in-2025">Manufacturing Comeback? Strategist Expects Tariffs To Help Small-Cap Stocks But Weigh On Consumers</a>
<h2 class="wp-block-heading">Automation &amp; Onshoring: A Tech Revolution</h2>
With the U.S. accelerating its onshoring efforts, automation and AI are emerging as the driving forces powering the shift.
Software companies and data centers are prepping for a revenue surge, with mega-cap tech upping its spending on data centers to $250 billion in 2025. 
Robotics and IoT hardware could also rebound from a sales plateau, making the automation sector one to watch. Companies enabling robotics and automation such as Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), ABB (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABBNY#OTC">ABBNY</a>), Rockwell Automation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), Zebra Technologies&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>), Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) and UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) come to mind.
<h2 class="wp-block-heading">Energy Independence Goes Nuclear</h2>
Energy's next frontier? Nuclear. With mega-cap tech giants eyeing modular nuclear reactors as a green and reliable power source, demand for uranium is heating up. Beyond the U.S., countries like Japan and Germany are also jumping on the nuclear bandwagon, signaling a global shift toward energy resilience.
U.S. companies such as Constellation Energy&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), Cameco&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) and NuScale Power&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) come to mind.
Helfstein's roadmap suggests a year of targeted strategies. By aligning portfolios with these U.S.-centric themes, investors might not just weather volatility—they could thrive in the chaos.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/24/12/42437267/berkshire-palantir-etfs-add-high-octane-trading-options-with-direxions-launch">Berkshire, Palantir ETFs Add High-Octane Trading Options With Direxion&#8217;s Launch</a></li>
</ul>
Photo: Shutterstock

Comments

UiPath

Unusual Options Activity for

뉴스

파트너 / 기고자

벤징가 글로벌